Medicure Stock Analysis

Medicure Stock Analysis Notes

About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medicure recorded a loss per share of 0.2. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 2nd of November 2012. Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovascular market in the United States. The company was founded in 1997 and is headquartered in Winnipeg, Canada. MEDICURE INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. To find out more about Medicure contact Albert Friesen at 204 487 7412 or learn more at https://www.medicure.com.

Medicure Investment Alerts

Medicure Largest EPS Surprises

View All Earnings Estimates

Medicure Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medicure's market, we take the total number of its shares issued and multiply it by Medicure's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Medicure Profitablity

The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.22) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.22.

Management Efficiency

Medicure has return on total asset (ROA) of (0.0563) % which means that it has lost $0.0563 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.129) %, meaning that it generated substantial loss on money invested by shareholders. Medicure's management efficiency ratios could be used to measure how well Medicure manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.06 in 2024. Return On Capital Employed is likely to climb to -0.04 in 2024. At this time, Medicure's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 16.1 M in 2024, whereas Other Assets are likely to drop slightly above 62.3 K in 2024.

Technical Drivers

As of the 12th of December 2024, Medicure secures the Downside Deviation of 7.39, risk adjusted performance of 0.0142, and Mean Deviation of 1.41. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medicure, as well as the relationship between them. Please verify Medicure standard deviation and the relationship between the treynor ratio and kurtosis to decide if Medicure is priced some-what accurately, providing market reflects its recent price of 0.98 per share.

Medicure Price Movement Analysis

Medicure Outstanding Bonds

Medicure Predictive Daily Indicators

Medicure Forecast Models

Medicure's time-series forecasting models are one of many Medicure's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medicure's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medicure prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medicure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medicure. By using and applying Medicure Stock analysis, traders can create a robust methodology for identifying Medicure entry and exit points for their positions.

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.